Table 3.
Descriptive Statistics | ||||||
---|---|---|---|---|---|---|
n | Minimum | Maximum | Average | Standard Deviation | ||
Aflibercept | ETDRS_0—before therapy | 90 | 35.0 | 80.0 | 59.9 | 14.08 |
Ranibizumab | ETDRS_0—before therapy | 54 | 35.0 | 80.0 | 60.7 | 12.18 |
Descriptive Statistics | ||||||
---|---|---|---|---|---|---|
n | Minimum | Maximum | Average | Standard Deviation | ||
Aflibercept | ETDRS_0—before therapy | 90 | 35.0 | 80.0 | 59.9 | 14.08 |
Ranibizumab | ETDRS_0—before therapy | 54 | 35.0 | 80.0 | 60.7 | 12.18 |